Details of the Drug Formulations

General Information of Drug (ID: DMGB5RE)

• Drug Name: Tranylcypromine Drug Info
• Synonyms: GJZ; Jatrosom; Parnate; Parnitene; Tranilcipromina; Transamine; Tranylcyprominum; Allphar Brand of Tranylcypromine Sulfate; Esparma Brand of Tranylcypromine Sulfate; GlaxoSmithKline Brand of Tranylcypromine Sulfate; Goldshield Brand of Tranylcypromine Sulfate; Link Brand of Tranylcypromine Sulfate; Racemic Tranylcypromine; SmithKline Brand of Tranylcypromine Sulfate; SKF 385; Trans 2 Phenylcyclopropylamine; D-Tranylcypromine; Dl-Tranylcypromine; Jatrosom (TN); L-Tranylcypromine; Parmodalin (TN); Parnate (TN); Parstelin (TN); SKF Trans-385; Sicoton (TN); Sulfate, Tranylcypromine; Tranilcipromina [INN-Spanish]; Transamine (TN); Transapin (TN); Tranylcypromine (INN); Tranylcypromine [INN:BAN]; Tranylcyprominum [INN-Latin]; Tylciprine (TN); Trans-2-Phenylcyclopropylamine; Trans-DL-2-Phenylcyclopropylamine; Trans-(-)-2-Phenylcyclopropanamine; Cyclopropanamine, 2-phenyl-, (1R-trans)-(9CI); (+)-(R)-Tranylcypromine; (+)-Tranylcypromine; (+)-trans-2-Phenylcyclopropylamine; (-)-Tranylcypromine; (1R)-2-phenylcyclopropan-1-amine; (1R,2R)-2-phenylcyclopropan-1-amine; (1R,2S)-2-phenylcyclopropan-1-amine; (1R,2S)-2-phenylcyclopropanamine; (1S)-2-phenylcyclopropan-1-amine; (1S,2R)-2-phenylcyclopropan-1-amine; (1S,2S)-2-phenylcyclopropan-1-amine; (2S)-2-phenylcyclopropan-1-amine; 2-Phenylcyclopropanamine; 2-phenylcyclopropan-1-amine

Indication

Disease Entry	ICD 11	Status	REF
Major depressive disorder	6A70.3	Approved	[1]
Prostate cancer	2C82.0	Patented	[2]

• Therapeutic Class: Antidepressants
• Cross-matching ID:
  PubChem CID: 19493
  ChEBI ID: CHEBI:94631
  CAS Number: 3721-26-4
  TTD ID: D0H0HJ
  ACDINA ID: D00697

Full List of Drug Formulations Containing This Drug

Tranylcypromine 10 mg tablet

Company	Formulation ID	FDA Description
GlaxoSmithKline	F21589	Anhydrous citric acid; Lactose; Fd&c red no. 40; D&c red no. 7; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Talc; Titanium dioxide; Croscarmellose sodium; Cellulose, microcrystalline; Gelatin
Covis Pharmaceuticals	F21590	Anhydrous citric acid; Lactose; Fd&c red no. 40; D&c red no. 7; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Talc; Titanium dioxide; Croscarmellose sodium; Cellulose, microcrystalline; Gelatin
Actavis Pharma	F21591	Anhydrous citric acid; Lactose; D&c red no. 7; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Talc; Titanium dioxide; Croscarmellose sodium; Polyethylene glycol 400; Carnauba wax; Cellulose, microcrystalline; Gelatin; Hypromellose 2910 (6 mpa.s); Polyethylene glycol 8000
Concordia Pharmaceuticals	F21592	Anhydrous citric acid; Lactose; D&c red no. 7; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Talc; Titanium dioxide; Croscarmellose sodium; Polyethylene glycol 400; Carnauba wax; Cellulose, microcrystalline; Gelatin; Hypromellose 2910 (6 mpa.s); Polyethylene glycol 8000
GlaxoSmithKline	F21595	Anhydrous citric acid; Lactose, unspecified form; Fd&c red no. 40; D&c red no. 7; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Talc; Titanium dioxide; Croscarmellose sodium; Gelatin, unspecified; Microcrystalline cellulose
Golden State Medical Supply	F21596	Fd&c red no. 40; Magnesium stearate; Calcium phosphate, dibasic, dihydrate; Talc; Titanium dioxide; Croscarmellose sodium; Polyethylene glycol 3350; Polyvinyl alcohol; Silicon dioxide; Cellulose, microcrystalline
Rising Pharmaceuticals	F21593	Lactose; Fd&c red no. 40; D&c red no. 7; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Citric acid monohydrate; Talc; Titanium dioxide; Croscarmellose sodium; Cellulose, microcrystalline; Gelatin
RemedyRepack	F21594	Lactose; Fd&c red no. 40; D&c red no. 7; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Citric acid monohydrate; Talc; Titanium dioxide; Croscarmellose sodium; Cellulose, microcrystalline; Gelatin
Par Pharmaceutical	F21597	Fd&c red no. 40; Magnesium stearate; Dibasic calcium phosphate dihydrate; Talc; Titanium dioxide; Croscarmellose sodium; Polyethylene glycol 3350; Silicon dioxide; Microcrystalline cellulose; Polyvinyl alcohol, unspecified

Tranylcypromine Sulfate 10mg tablet

Company	Formulation ID	FDA Description
Actavis Pharma	F23583	Cellulose, Microcrystalline; Anhydrous Citric Acid; Croscarmellose Sodium; D&C Red No. 7; Fd&C Blue No. 2; Fd&C Yellow No. 6; Gelatin; Lactose; Magnesium Stearate; Talc; Titanium Dioxide; Carnauba Wax; Hypromellose 2910 (6 Mpa.S); Polyethylene Glycol 400; Polyethylene Glycol 8000
Concordia Pharmaceuticals	F23584	Cellulose, Microcrystalline; Anhydrous Citric Acid; Croscarmellose Sodium; D&C Red No. 7; Fd&C Blue No. 2; Fd&C Yellow No. 6; Gelatin; Lactose; Magnesium Stearate; Talc; Titanium Dioxide; Carnauba Wax; Polyethylene Glycol 400; Polyethylene Glycol 8000; Hypromellose 2910(6 Mpa.S)
Alvogen	F23585	Microcrystalline Cellulose; Starch, Corn; Carboxymethylcellulose Sodium, Unspecified; Calcium Sulfate, Unspecified Form; Croscarmellose Sodium; Magnesium Stearate; Hypromellose, Unspecified; Polyethylene Glycol, Unspecified; Talc; Titanium Dioxide; Fd&C Red No. 40; Fd&C Blue No. 2; Fd&C Yellow No. 6

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
• [2] Novel monoamine oxidase inhibitors: a patent review (2012 - 2014).Expert Opin Ther Pat. 2015 Jan;25(1):91-110.